The peripheral metabolism of glucose involves movement across the cell membrane of tissues followed by intracellular processing via oxidative and non-oxidative pathways. Peripheral insulin resistance is a well documented abnormality in obesity and Type II diabetes mellitus (NIDDM) and is due primarily to a post-receptor (post-binding) once it enters the cells and if abnormalities in intracellular metabolism might play a role in the insulin resistance of these disorders. Due to insulin resistance, at any given level of serum insulin and glucose, lower rates of glucose disposal result in reduced rates of glucose flux through intracellular pathways compared to non-diabetic nonobese individuals. Because of this, accurate comparisons of intermediary metabolism or delineation of any intrinsic intracellular metabolic defects independent of the decreased glucose disposal rates are difficult to make. In these studies, we plan to evaluate the effects of obesity and NIDDM on in vivo and in vitro intracellular glucose metabolism to determine whether intrinsic defects of intracellular glucose metabolism exist in NIDDM and/or obesity or whether these defects are merely secondary to the decreased rate of glucose entry into the cell. We propose to accomplish this by using levels of hyperinsulinemia and hyperglycemia designed to attain similar rates of in vivo glucose disposal in comparably matched groups of non-obese, obese and NIDDM subjects. To conduct these studies the insulin-glucose clamp technique will be employed to measure glucose uptake rates in conjunction with simultaneous computerized open circuit indirect calorimetry to quantitate oxidative and non-oxidative glucose metabolism (NOGM). To determine whether corresponding changes are occurring in the primary peripheral target organ, samples or quadriceps femoris muscle will be obtained by needle biopsy during these studies for determination of glycolytic pathway metabolites and the rate limiting enzyme for glycogen synthesis, glycogen synthase. It is anticipated that these studies will delineate the importance of insulin, glucose and overall glucose disposal on the metabolic fate of glucose and indicate whether an intrinsic defect(s) in the intermediary metabolic handling of glucose exists in obesity and NIDDM.

Project Start
1988-09-30
Project End
1993-08-31
Budget Start
1991-09-01
Budget End
1992-08-31
Support Year
4
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
Schools of Medicine
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Shah, Meena; Adams-Huet, Beverley; Bantle, John P et al. (2005) Effect of a high-carbohydrate versus a high--cis-monounsaturated fat diet on blood pressure in patients with type 2 diabetes. Diabetes Care 28:2607-12
Nikoulina, S E; Ciaraldi, T P; Abrams-Carter, L et al. (1997) Regulation of glycogen synthase activity in cultured skeletal muscle cells from subjects with type II diabetes: role of chronic hyperinsulinemia and hyperglycemia. Diabetes 46:1017-24
Chung, J; Henry, R R (1996) Mechanisms of tumor-induced hypoglycemia with intraabdominal hemangiopericytoma. J Clin Endocrinol Metab 81:919-25
Henry, R R; Ciaraldi, T P; Abrams-Carter, L et al. (1996) Glycogen synthase activity is reduced in cultured skeletal muscle cells of non-insulin-dependent diabetes mellitus subjects. Biochemical and molecular mechanisms. J Clin Invest 98:1231-6
Chung, J W; Suh, K I; Joyce, M et al. (1995) Contribution of obesity to defects of intracellular glucose metabolism in NIDDM. Diabetes Care 18:666-73
Henry, R R; Abrams, L; Nikoulina, S et al. (1995) Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects. Comparison using human skeletal muscle cell cultures. Diabetes 44:936-46
Ciaraldi, T P; Abrams, L; Nikoulina, S et al. (1995) Glucose transport in cultured human skeletal muscle cells. Regulation by insulin and glucose in nondiabetic and non-insulin-dependent diabetes mellitus subjects. J Clin Invest 96:2820-7
Suh, K I; Song, Y M; Murata, C et al. (1995) Role of basal insulin in maintenance of intracellular glucose metabolic pathways in non-insulin-dependent diabetes mellitus. Metabolism 44:41-6
Kusari, J; Kenner, K A; Suh, K I et al. (1994) Skeletal muscle protein tyrosine phosphatase activity and tyrosine phosphatase 1B protein content are associated with insulin action and resistance. J Clin Invest 93:1156-62
Nolan, J J; Freidenberg, G; Henry, R et al. (1994) Role of human skeletal muscle insulin receptor kinase in the in vivo insulin resistance of noninsulin-dependent diabetes mellitus and obesity. J Clin Endocrinol Metab 78:471-7

Showing the most recent 10 out of 26 publications